Imugene, a clinical-stage immuno-oncology company, is celebrating more than two years of “complete response” for one of its bile duct cancer trial participants in its CF33-MAST-VAXINIA trial.
Cuballing will welcome a new CEO in September who will bring consistency and stability thanks to his extensive network of political and governmental authorities. Chris Paget will join the County of Cuballing on September 23 for a three-year term and will be the county's third CEO in four years following the retirement of Stan Scott.